Recent Advances for Enhancing Drug Metabolizing Functions of Hepatocyte-like Cells Derived from Human Pluripotent Stem Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김종훈 | - |
dc.contributor.author | 한지유 | - |
dc.date.accessioned | 2021-09-04T21:17:26Z | - |
dc.date.available | 2021-09-04T21:17:26Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1738-429X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/95158 | - |
dc.description.abstract | Hepatocyte-like cells (HLCs) derived from human pluripotent stem cells are a promising cell source for drug screening and toxicity tests. Thus, various hepatic differentiating protocols have been developed, leading to a hepatic differentiation efficiency of approximately 90%. However, HLC drug metabolizing ability remains very low compared to human primary hepatocytes. In order to overcome this problem, several alternative methods, such as, co-culture, three-dimensional (3D) culture, bioreactor, nanochip-based, etc., have been developed, but optimization to produce fully functional HLCs is ongoing. Recently, our group reported that repeated exposure of HLCs to xenobiotics can improve the expression of hepatic metabolizing enzymes such as cytochrome P450s (CYPs) and glutathione S-transferases (GSTs). These data suggest that we should develop strategies for differentiating cells into mature HLCs by more closely mimicking in vivo fetal and postnatal liver development. Here, we review the current development of alternative methods for enhancing the drug metabolizing functions of HLCs derived from human embryonic stem cells, human-induced pluripotent stem cells, and mesenchymal stem cells as used for drug screening and toxicity tests. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | 한양대학교 의과대학 | - |
dc.title | Recent Advances for Enhancing Drug Metabolizing Functions of Hepatocyte-like Cells Derived from Human Pluripotent Stem Cells | - |
dc.title.alternative | Recent Advances for Enhancing Drug Metabolizing Functions of Hepatocyte-like Cells Derived from Human Pluripotent Stem Cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 한지유 | - |
dc.identifier.doi | 10.7599/hmr.2015.35.4.196 | - |
dc.identifier.bibliographicCitation | Hanyang Medical Reviews, v.35, no.4, pp.196 - 206 | - |
dc.relation.isPartOf | Hanyang Medical Reviews | - |
dc.citation.title | Hanyang Medical Reviews | - |
dc.citation.volume | 35 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 196 | - |
dc.citation.endPage | 206 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART002048592 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordAuthor | Bioreactors | - |
dc.subject.keywordAuthor | Coculture Techniques | - |
dc.subject.keywordAuthor | Hepatocytes | - |
dc.subject.keywordAuthor | Stem Cells | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.